Rep. April McClain Delaney Sells Bio-Techne Corp Stock

The Democratic representative from Maryland disclosed the sale of between $1,001 and $15,000 in Bio-Techne shares.

Apr. 10, 2026 at 12:12am

Got story updates? Submit your updates here. ›

An extreme close-up of the inner workings of a high-tech laboratory instrument, with gears, sensors, and other components visible in a dramatic, industrial composition, conveying the complex financial and technological infrastructure of the biotech industry.The intricate machinery powering the biotech sector faces heightened scrutiny as a member of Congress discloses a stock sale.Minneapolis Today

Representative April McClain Delaney (Democratic-Maryland) recently sold shares of Bio-Techne Corp (NASDAQ:TECH). In a filing disclosed on April 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in Bio-Techne stock on March 26th.

Why it matters

As a member of Congress, Representative McClain Delaney's financial transactions are subject to public disclosure and scrutiny. This sale of Bio-Techne stock raises questions about potential conflicts of interest and whether elected officials are making investment decisions based on non-public information.

The details

Representative McClain Delaney also recently made other trades in Bio-Techne stock. The company's shares have traded in the range of $46.01 to $72.16 over the past year, with the stock currently priced at around $55.57.

  • Representative McClain Delaney disclosed the stock sale on April 6, 2026.
  • The stock sale occurred on March 26, 2026.

The players

Representative April McClain Delaney

A Democratic member of the U.S. House of Representatives from Maryland's 6th Congressional District, who assumed office in January 2025 and is running for re-election in 2026.

Bio-Techne Corp

A global life sciences company that develops, manufactures and sells high-quality reagents, instruments and services for the research, diagnostic and bioprocessing markets.

Got photos? Submit your photos here. ›

What’s next

The House Ethics Committee may investigate the stock sale to ensure Representative McClain Delaney did not use any non-public information to inform her trading decisions.

The takeaway

This case highlights the ongoing scrutiny and concerns around members of Congress engaging in stock trading, particularly in industries that may be impacted by legislation or oversight from their committees. It underscores the need for stronger rules and transparency around elected officials' financial activities.